Unraveling payer trends: Critical insights on healthcare decision-making strategies
Our consultants’ cutting-edge and most recent research delved into a wide range of topics including US payer perspectives on value assessment information (VAI), US payer management of cell and gene therapies (CGTs), leveraging pre-approval information (PIE) for coverage decisions, employing artificial intelligence (AI) in literature reviews, exploring patient early access programs in the UK and key EU countries, and more.
Three pivotal trends in US payer perceptions emerged:
- VAI plays a vital role in payer decisions
- Payers are closely monitoring the costs of CGTs
- Payer decision-making is enhanced through PIE
Read the white paper to access our research, explore the results from studies involving US payers and healthcare decision makers, and delve into the insights our consultants discovered.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.